Physicians Financial Services’s Unilever UL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $508K | Hold |
8,444
| – | – | 0.13% | 80 |
|
|
2026
Q1 | $481K | Sell |
8,444
-384
| -4% | -$25.7K | 0.13% | 80 |
|
|
2025
Q4 | $577K | Sell |
8,828
-192
| -2% | -$12.9K | 0.15% | 79 |
|
|
2025
Q3 | $602K | Hold |
9,020
| – | – | 0.16% | 79 |
|
|
2025
Q2 | $621K | Sell |
9,020
-89
| -1% | -$6.25K | 0.19% | 78 |
|
|
2025
Q1 | $610K | Sell |
9,109
-222
| -2% | -$14.3K | 0.19% | 74 |
|
|
2024
Q4 | $595K | Sell |
9,331
-201
| -2% | -$13.6K | 0.18% | 77 |
|
|
2024
Q3 | $697K | Buy |
9,532
+89
| +0.9% | +$6.15K | 0.22% | 71 |
|
|
2024
Q2 | $584K | Buy |
9,443
+54
| +0.6% | +$3.19K | 0.19% | 78 |
|
|
2024
Q1 | $530K | Hold |
9,389
| – | – | 0.19% | 81 |
|
|
2023
Q4 | $512K | Sell |
9,389
-390
| -4% | -$21K | 0.19% | 82 |
|
|
2023
Q3 | $543K | Hold |
9,779
| – | – | 0.22% | 75 |
|
|
2023
Q2 | $573K | Hold |
9,779
| – | – | 0.23% | 75 |
|
|
2023
Q1 | $571K | Hold |
9,779
| – | – | 0.24% | 72 |
|
|
2022
Q4 | $554K | Hold |
9,779
| – | – | 0.25% | 73 |
|
|
2022
Q3 | $482K | Sell |
9,779
-50
| -0.5% | -$2.61K | 0.23% | 75 |
|
|
2022
Q2 | $507K | Sell |
9,829
-127
| -1% | -$6.47K | 0.23% | 78 |
|
|
2022
Q1 | $510K | Sell |
9,956
-89
| -0.9% | -$4.95K | 0.19% | 81 |
|
|
2021
Q4 | $608K | Sell |
10,045
-297
| -3% | -$17.6K | 0.22% | 76 |
|
|
2021
Q3 | $631K | Hold |
10,342
| – | – | 0.26% | 72 |
|
|
2021
Q2 | $681K | Sell |
10,342
-750
| -7% | -$49.9K | 0.28% | 69 |
|
|
2021
Q1 | $697K | Buy |
11,092
+560
| +5% | +$35.7K | 0.3% | 68 |
|
|
2020
Q4 | $715K | Buy |
10,532
+2,410
| +30% | +$164K | 0.35% | 64 |
|
|
2020
Q3 | $564K | Buy |
8,122
+73
| +0.9% | +$4.87K | 0.28% | 70 |
|
|
2020
Q2 | $497K | Sell |
8,049
-86
| -1% | -$5.14K | 0.27% | 70 |
|
|
2020
Q1 | $463K | Sell |
8,135
-3,378
| -29% | -$212K | 0.32% | 68 |
|
|
2019
Q4 | $740K | Buy |
11,513
+1
| +0% | +$66 | 0.4% | 64 |
|
|
2019
Q3 | $778K | Sell |
11,512
-177
| -2% | -$12.3K | 0.44% | 61 |
|
|
2019
Q2 | $815K | Buy |
11,689
+88
| +0.8% | +$5.97K | 0.48% | 61 |
|
|
2019
Q1 | $753K | Hold |
11,601
| – | – | 0.47% | 60 |
|
|
2018
Q4 | $682K | Buy |
11,601
+2,979
| +35% | +$180K | 0.5% | 58 |
|
|
2018
Q3 | $534K | Hold |
8,622
| – | – | 0.37% | 70 |
|
|
2018
Q2 | $536K | Hold |
8,622
| – | – | 0.4% | 68 |
|
|
2018
Q1 | $534K | Sell |
8,622
-2,045
| -19% | -$124K | 0.42% | 68 |
|
|
2017
Q4 | $664K | Hold |
10,667
| – | – | 0.51% | 62 |
|
|
2017
Q3 | $696K | Hold |
10,667
| – | – | 0.57% | 55 |
|
|
2017
Q2 | $649K | Sell |
10,667
-45
| -0.4% | -$2.68K | 0.55% | 59 |
|
|
2017
Q1 | $595K | Buy |
10,712
+356
| +3% | +$18K | 0.51% | 65 |
|
|
2016
Q4 | $538K | Buy |
10,356
+177
| +2% | +$8.25K | 0.44% | 67 |
|
|
2016
Q3 | $542K | Hold |
10,179
| – | – | 0.45% | 66 |
|
|
2016
Q2 | $549K | Sell |
10,179
-177
| -2% | -$9.09K | 0.48% | 63 |
|
|
2016
Q1 | $526K | Hold |
10,356
| – | – | 0.48% | 63 |
|
|
2015
Q4 | $502K | Buy |
+10,356
| New | +$505K | 0.46% | 64 |
|
Other funds holding UL
HCM
SRIM
MR
CAI
CCMIC
RRAM
FMI
TWC
CGH
QI
Physicians Financial Services's UL Position: Q2 2026 in Review
Physicians Financial Services held its Unilever (UL) position steady in Q2 2026 at 8,444 shares worth $508K. The position accounts for 0.13% of the portfolio, ranked #80.
Physicians Financial Services first reported a position in UL in Q4 2015 and has held it in 43 quarters since. The position peaked at $815K in Q2 2019. 385 funds tracked by Wall St. Rank hold UL as of Q2 2026.
- Physicians Financial Services held 8,444 shares of Unilever worth $508K as of Q2 2026.
- Physicians Financial Services left its Unilever share count unchanged in Q2 2026.
- Unilever made up 0.13% of Physicians Financial Services's portfolio in Q2 2026, its #80 holding.
- Physicians Financial Services first reported a position in Unilever in Q4 2015 and has held it in 43 quarters since.
- Physicians Financial Services's Unilever position peaked at $815K in Q2 2019.
- 385 funds tracked by Wall St. Rank held Unilever as of Q2 2026.
Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.